Brief: EVE Health Confirms Australian Regulatory Path For Initial Access To ED & Dysmenorrhoea Products
21/07/2025 02:35
July 21 (Reuters) - Eve Health Group Ltd EVE.AX: AUSTRALIAN REGULATORY PATH CONFIRMED FOR INITIAL ACCESS TO ED & DYSMENORRHOEA PRODUCTS COMMERCIAL ROLLOUT IN AUSTRALIA EXPECTED TO COMMENCE BEFORE END OF 2025 Further company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Eve Health
See all newsBrief: Eve Health Appoints Ben Rohr As Chief Executive Officer
Australia's EVE Health slips on discounted placement
Brief: Eve Health Group Seeks Trading Halt For Capital Raising Consideration And Planning
Brief: Eve Health Signs Telehealth Services Agreement With Hubmed
Brief: Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share